Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study

Neoadjuvant chemotherapy (NAC) using the combination of anthracycline and taxanes is the standard regimen for patients with primary breast cancer. Among the taxanes, conventional paclitaxel (PTX) and docetaxel have usually been adopted in the neoadjuvant or adjuvant setting. Nanoparticle albumin-bou...

Descripción completa

Detalles Bibliográficos
Autores principales: Shizuku, Masato, Shibata, Masahiro, Shimizu, Yoshimi, Takeuchi, Dai, Mizuno, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548255/
https://www.ncbi.nlm.nih.gov/pubmed/33132430
http://dx.doi.org/10.18999/nagjms.82.3.457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548255/
https://www.ncbi.nlm.nih.gov/pubmed/33132430
http://dx.doi.org/10.18999/nagjms.82.3.457

Ejemplares similares